FDA approval is realistically a 2029 to 2030 event
Insurance coverage for GLP-1 medications like Ozempic has become increasingly restrictive, with most major carriers including Aetna limiting approval to patients with diagnosed type 2 diabetes rather than obesity alone
People using semaglutide for weight loss or diabetes may notice new or worsening acid reflux symptoms
And if cost or eligibility is a barrier, the right thing to do is talk to your GP or a healthcare professional rather than turning to an unproven alternative. Ian Budd, Prescribing Pharmacist at Chemist4U Alternatives to GLP-1 patches If you're looking for a safe, effective, and clinically approved weight loss treatment, here are the options you should consider
[DOI] [PMC free article] [PubMed] [Google Scholar] 55.Zou Y, Li H, Graham ET, Deik AA, Eaton JK, Wang W, Sandoval-Gomez G, Clish CB, Doench JG, Schreiber SL